Platinum Doublet: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

15

Conditions studied

19

US states with sites

3

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Conditions being studied

Condition	Trials
Autoimmune Disease	1
Crohn Disease	1
Crohn's disease	1
Dermatomyositis	1
Hematopoietic and Lymphoid Cell Neoplasm	1
Inflammatory Bowel Disease	1
Lung cancer	1
Lupus	1
Malignant Solid Neoplasm	1
Multiple Sclerosis	1
Non-small Cell Lung Cancer (NSCLC)	1
Psoriasis	1
Psoriatic Arthritis	1
Rheumatoid Arthritis	1
Sjogren Syndrome	1

Recruiting trials involving Platinum Doublet

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC
NCT06977074 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 260 locations

Common questions

How many recruiting trials involve Platinum Doublet?

2 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.